225 related articles for article (PubMed ID: 9392536)
1. 15 years experience with helium ion radiotherapy for uveal melanoma.
Castro JR; Char DH; Petti PL; Daftari IK; Quivey JM; Singh RP; Blakely EA; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):989-96. PubMed ID: 9392536
[TBL] [Abstract][Full Text] [Related]
2. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
4. Ten-year follow-up of helium ion therapy for uveal melanoma.
Char DH; Kroll SM; Castro J
Am J Ophthalmol; 1998 Jan; 125(1):81-9. PubMed ID: 9437317
[TBL] [Abstract][Full Text] [Related]
5. Ciliary body melanoma treated with helium particle irradiation.
Decker M; Castro JR; Linstadt DE; Char D; Petti PL; Quivey JM; Ahn D
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):243-7. PubMed ID: 2118491
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of helium ion irradiation of uveal melanoma.
Linstadt D; Castro J; Char D; Decker M; Ahn D; Petti P; Nowakowski V; Quivey J; Phillips TL
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):613-8. PubMed ID: 2120158
[TBL] [Abstract][Full Text] [Related]
7. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up of helium ion therapy for uveal melanoma.
Char DH; Castro JR; Kroll SM; Irvine AR; Quivey JM; Stone RD
Arch Ophthalmol; 1990 Feb; 108(2):209-14. PubMed ID: 2302103
[TBL] [Abstract][Full Text] [Related]
9. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
10. The risk of enucleation after proton beam irradiation of uveal melanoma.
Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
[TBL] [Abstract][Full Text] [Related]
11. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma.
Daftari IK; Char DH; Verhey LJ; Castro JR; Petti PL; Meecham WJ; Kroll S; Blakely EA
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):997-1010. PubMed ID: 9392537
[TBL] [Abstract][Full Text] [Related]
12. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.
Char DH; Quivey JM; Castro JR; Kroll S; Phillips T
Ophthalmology; 1993 Oct; 100(10):1547-54. PubMed ID: 8414414
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanomas. Conservation treatment.
Munzenrider JE
Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
[TBL] [Abstract][Full Text] [Related]
14. Neovascular glaucoma after helium ion irradiation for uveal melanoma.
Kim MK; Char DH; Castro JL; Saunders WM; Chen GT; Stone RD
Ophthalmology; 1986 Feb; 93(2):189-93. PubMed ID: 2419816
[TBL] [Abstract][Full Text] [Related]
15. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
16. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
18. Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study.
Linstadt D; Char DH; Castro JR; Phillips TL; Quivey JM; Reimers M; Hannigan J; Collier JM
Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):347-52. PubMed ID: 3403315
[TBL] [Abstract][Full Text] [Related]
19. Eye retention after proton beam radiotherapy for uveal melanoma.
Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
[TBL] [Abstract][Full Text] [Related]
20. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
